Chemoenzymatic Synthesis of Homogeneous Heparan Sulfate and Chondroitin Sulfate Chimeras.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
20 05 2022
Historique:
pubmed: 15 4 2022
medline: 24 5 2022
entrez: 14 4 2022
Statut: ppublish

Résumé

Heparan sulfate (HS) and chondroitin sulfate (CS) are two structurally distinct natural polysaccharides. Here, we report the synthesis of a library of seven structurally homogeneous HS and CS chimeric dodecasaccharides (12-mers). The synthesis was accomplished using six HS biosynthetic enzymes and four CS biosynthetic enzymes. The chimeras contain a CS domain on the reducing end and a HS domain on the nonreducing end. The synthesized chimeras display anticoagulant activity as measured by both in vitro and ex vivo experiments. Furthermore, the anticoagulant activity of

Identifiants

pubmed: 35420777
doi: 10.1021/acschembio.2c00146
pmc: PMC9294993
mid: NIHMS1821819
doi:

Substances chimiques

Anticoagulants 0
Chondroitin Sulfates 9007-28-7
Heparitin Sulfate 9050-30-0
Sulfotransferases EC 2.8.2.-

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1207-1214

Subventions

Organisme : NIGMS NIH HHS
ID : R44 GM134738
Pays : United States
Organisme : NIGMS NIH HHS
ID : R44 GM123792
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL158932
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL094463
Pays : United States
Organisme : NIGMS NIH HHS
ID : R41 GM123792
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144970
Pays : United States

Références

FEBS J. 2019 Aug;286(15):2921-2936
pubmed: 30932321
Carbohydr Res. 2008 Jan 14;343(1):39-47
pubmed: 17950715
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9311-9317
pubmed: 32277030
Metab Eng. 2012 Mar;14(2):81-90
pubmed: 22326251
Cell Mol Life Sci. 2000 Feb;57(2):276-89
pubmed: 10766023
Nat Prod Rep. 2014 Dec;31(12):1676-85
pubmed: 25197032
Sci Transl Med. 2017 Sep 6;9(406):
pubmed: 28878012
J Biol Chem. 2016 Feb 26;291(9):4399-406
pubmed: 26742844
Nat Chem Biol. 2014 Apr;10(4):248-50
pubmed: 24561662
Pflugers Arch. 2007 Jun;454(3):345-59
pubmed: 17256154
Med Res Rev. 2002 Jan;22(1):1-25
pubmed: 11746174
Nat Methods. 2018 Nov;15(11):889-899
pubmed: 30377379
Science. 2011 Oct 28;334(6055):498-501
pubmed: 22034431
Chemistry. 2009 Sep 21;15(37):9579-95
pubmed: 19621396
Biochem Biophys Res Commun. 2012 Jun 29;423(2):344-9
pubmed: 22659745
Dev Neurobiol. 2011 Nov;71(11):1073-89
pubmed: 21898855
J Thromb Haemost. 2020 Feb;18(2):390-398
pubmed: 31573759
Blood Adv. 2018 Nov 27;2(22):3360-3392
pubmed: 30482768
J Org Chem. 2019 Jun 7;84(11):7418-7425
pubmed: 31066281
Int J Biochem Cell Biol. 2012 Apr;44(4):582-6
pubmed: 22265655
Pharmaceuticals (Basel). 2017 Jul 22;10(3):
pubmed: 28737679
ACS Cent Sci. 2020 Jul 22;6(7):1199-1207
pubmed: 32724854
Annu Rev Biochem. 2002;71:435-71
pubmed: 12045103
Nature. 2007 Apr 26;446(7139):1030-7
pubmed: 17460664
Carbohydr Res. 2015 Feb 11;403:60-8
pubmed: 25088334
PLoS One. 2014 Nov 05;9(11):e111806
pubmed: 25372710
Annu Rev Cell Dev Biol. 2006;22:375-407
pubmed: 16805665
Angew Chem Int Ed Engl. 2017 Sep 18;56(39):11784-11787
pubmed: 28731518

Auteurs

Eduardo Stancanelli (E)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Wei Liu (W)

Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, PR China.

Rylee Wander (R)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Jine Li (J)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

Zhangjie Wang (Z)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Katelyn Arnold (K)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Guowei Su (G)

Glycan Therapeutics, 617 Hutton Street, Raleigh, North Carolina 27606, United States.

Adam Kanack (A)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55904, United States.

Truong Quang Pham (TQ)

Glycan Therapeutics, 617 Hutton Street, Raleigh, North Carolina 27606, United States.

Vijayakanth Pagadala (V)

Glycan Therapeutics, 617 Hutton Street, Raleigh, North Carolina 27606, United States.

Anand Padmanabhan (A)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55904, United States.

Yongmei Xu (Y)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Jian Liu (J)

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Articles similaires

UK Foot and Ankle Thromboembolism (UK-FATE).

Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra et al.
1.00
Humans Venous Thromboembolism Male Female United Kingdom
Animals Male Antioxidants Rats, Wistar Rats
Humans Female Diabetic Ketoacidosis Aged Infarction
Humans Cross-Sectional Studies Drug Approval Dabigatran United States

Classifications MeSH